Preeclampsia and gestational hypertension, a risk factor for cardiovascular health and quality of life
DOI:
https://doi.org/10.35381/s.v.v8i16.4038Keywords:
hypertensive disorders of pregnancy, preeclampsia, gestational hypertension, cardiovascular complications, quality of lifeAbstract
Objective: To determine the long-term cardiovascular complications in patients with pre-eclampsia and gestational hypertension and how they influence their quality of life. Method: Systematic review of documents belonging to the health field, especially the area of obstetrics and gynecology whose studies analyzed the history of preeclampsia and gestational hypertension and their relationship with the development of long-term cardiovascular disorders. Results: 32 studies were analyzed, which highlight the importance of considering the history of hypertensive disorders during pregnancy as risk factors for the subsequent development of cardiovascular diseases such as chronic arterial hypertension, ischemic heart disease, venous thromboembolism, death from acute cardiovascular events, and coronary calcifications. Conclusion: It is crucial to regularly monitor and maintain healthy lifestyle habits after suffering from hypertensive disorders during pregnancy to prevent the development of cardiovascular disease in the long term.
Downloads
References
Phoswa WN, Khaliq OP. The role of oxidative stress in hypertensive disorders of pregnancy (preeclampsia, gestational hypertension) and metabolic disorder of pregnancy (gestational diabetes mellitus). Oxidative medicine and cellular longevity. 2021;1:5581570. https://doi.org/10.1155/2021/5581570
Jiang L, Tang K, Magee LA, von Dadelszen P, Ekeroma A, Li X, Zhang E, Bhutta, Z. A. A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nature Reviews Endocrinology. 2022;18(12):760-775. https://doi.org/10.1038/s41574-022-00734-y
Rojas-Pérez L, Rojas-Cruz L, Villagómez-Vega M, Rojas-Cruz A, Rojas-Cruz A. Preeclampsia - eclampsia diagnóstico y tratamiento [Preeclampsia - eclampsia diagnosis and treatment]. Rev Eugenio Espejo. 2019;13(2):79–91. https://n9.cl/q8n3g
Ernst R, Acoff E, Hsu A. A Systematic Review Investigating Disparities in Maternal Mortality in Latin American Countries. Obstetrics & Gynecology. 2024;141(5S): 52S-53S. https://doi.org/10.1097/01.AOG.0000930424.33722.e2
Tejera E, Sánchez ME, Henríquez-Trujillo AR, Pérez Castillo Y, Coral-Almeida M. A population-based study of preeclampsia and eclampsia in Ecuador: ethnic, geographical and altitudes differences. BMC Pregnancy Childbirth. 2021;21:116. https://doi.org/10.1186/s12884-021-03602-1
Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel J, Souza JP. Preeclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization multicountry survey on maternal and Newborn health. BJOG An Int J Obstet Gynaecol. 2014;121:14-24. https://doi.org/10.1111/1471-0528.12629
Velumani V, Durán Cárdenas C, Hernández Gutiérrez LS. Preeclampsia: una mirada a una enfermedad mortal. [Preeclampsia: a look at a deadly disease]. Rev la Fac Med. 2021;64(5):7–18. https://n9.cl/dwjxh
Dubuc KVP, Torres PAV, Villegas YG, Paredes LCV. Hypertensive disorders of pregnancy: ratio of protein/creatinine index in sporadic urine and proteinuria in 24 hours. Rev Obstet Ginecol Venez. 2022;82(3):297–308. https://n9.cl/qyai5n
Larco-Coloma JN, Ágreda-Saraguro DB, Bailón-Pereira CV, Granja-Casanova S, Eduardo Javier EJ, Cevallos-Ariza FX. Approach of Preeclampsia without Signs of Severity. Int J Med Surg Sci. 2023;1–11. https://n9.cl/4g7a1b
ACOG Publications. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):E237-260. https://doi.org/10.1097/AOG.0000000000003891
Chimbo C, Mariño M, Chimbo T, Caicedo C. Factores de riesgo y predictores de preeclampsia: una mirada al futuro [Risk factors and predictors of preeclampsia: a look into the future]. Rev Latinoam Hipertens. 2018;13. https://n9.cl/prcz6
Salamanca-Sánchez AL, Nieves-Díaz LA, Arenas-Cárdenas YM. Preeclampsia: prevalencia y factores asociados en gestantes de una institución de salud de Boyacá en el periodo 2015 a 2017 [Preeclampsia: prevalence and associated factors in pregnant women in a health institution of Boyacá in the period 2015 to 2017]. Rev Investig en Salud Univ Boyacá. 2019;6(2):40–52. https://n9.cl/dk24q0
Fernández Alba JJ, Mesa Páez C, Vilar Sánchez Á, Soto Pazos E, González Macías M del C, Serrano Negro E, et al. Overweight and obesity at risk factors for hypertensive states of pregnancy: A retrospective cohort study. Nutr Hosp. 2018;35(4):874–80. https://n9.cl/cz45w
Duarte MJ, Ezeta MME, Sánchez RG, Lee-Eng V, Romero FS. Factores de riesgo asociados con preeclampsia severa (con criterios de severidad) [Risk factors associated with severe preeclampsia (with severity criteria)]. Med Int Méx 2022;38(1):99-108. https://doi.org/10.24245/mim.v38i1.3691
Checya-Segura J, Hugo Moquillaza-Alcántara V, Víctor C, Alcántara HM. Factores asociados con preeclampsia severa en pacientes atendidas en dos hospitales de Huánuco, Perú [Factors associated with severe preeclampsia in pregnant women seen in two hospitals in Huánuco, Peru]. Ginecol Obstet Mex. 2019;87(5):295–301. https://doi.org/10.24245/gom.v87i5.2753
Elawad T, Scott G, Bone JN, Elwell H, Lopez CE, Filippi V, et al. Risk factors for pre-eclampsia in clinical practice guidelines: Comparison with the evidence. BJOG An Int J Obstet Gynaecol. 2024;131(1):46–62. https://doi.org/10.1111/1471-0528.17320
Pereira J, Pereira Y, Quirós L. Actualización en preeclampsia [Update in preeclampsia]. Rev Medica Sinerg. 2020;5(1). https://n9.cl/dblgg
Pankiewicz K, Szczerba E, Maciejewski T, Fijałkowska A. Non-obstetric complications in preeclampsia. Przeglad Menopauzalny. 2019;18(2):99-109. https://doi.org/10.5114%2Fpm.2019.85785
Galván-Luna A, Peña-Vega CJ, Medina-Hernández EO, Zavala-Barrios B, Galván-Luna A, Peña-Vega CJ, et al. Preeclampsia como factor de riesgo de padecer insuficiencia renal crónica y años de supervivencia [Preeclampsia as a risk factor for chronic renal failure and survival years]. Ginecol Obstet Mex. 2021;89(6):444-452. https://n9.cl/bjkra
Romero J, Ramírez A, Gutiérrez C. Preeclampsia, ¿factor de riesgo cardiovascular a futuro en madres y descendencia? [Preeclampsia, future cardiovascular risk in mothers and offspring?] Rev Medica Sinerg. 2023;8(6):132-145. https://doi.org/10.31434/rms.v8i6.1058
Gloria Valdés S. Preeclampsia and cardiovascular disease: An integrated approach to detect the subclinical stages of obstetrical and cardiovascular complications. Revista Chilena de Obstetricia y Ginecologia. 2020;38(2):185-200. http://doi.org/10.4067/S0718-85602019000200132
Villalaín C, Herraiz I, Fernández L, Ruiz G, Morales E, Solís J, et al. Salud cardiovascular y renal en la mujer: la preeclampsia como marcador de riesgo [Cardiovascular and renal health: Preeclampsia as a risk marker]. Nefrología. 2023;43(3):269-280. https://doi.org/10.1016/j.nefro.2022.04.010
Muñoz-Ortiz E, Velásquez-Penagos JA, Gándara-Ricardo JA, Múnera-Echeverri AG. Alteraciones del embarazo como factores de riesgo cardiovascular [Pregnancy alterations as cardiovascular risk factors]. Rev Colomb Cardiol. 2022;29(2):123–30. https://n9.cl/5nia4
Rodríguez M. Guías NICE 2019 sobre tratamiento de los trastornos hipertensivos del embarazo. La visión del nefrólogo [NICE guidelines 2019 on management of hypertensive disorders of pregnancy. The nephrologist's view]. NefroPlus. 2020;12(1):15–9. https://n9.cl/l05mg
Del-Sueldo MA, Mendonça-Rivera MA, Sánchez-Zambrano MB, Zilberman J, Múnera-Echeverri AG, Paniagua M, et al. Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women. Arch Cardiol Mex. 2022;92(92). https://doi.org/10.24875/acm.22000071
Karam G, Agarwal A, Sadeghirad B, Jalink M, Hitchcock CL, Ge L, et al. Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis. BMJ. 2023;380:e072003. https://doi.org/10.1136/bmj-2022-072003
Brown MA, Roberts L, Hoffman A, Henry A, Mangos G, O’sullivan A, et al. Recognizing cardiovascular risk after preeclampsia: The P4 study. J Am Heart Assoc. 2020;9(22):18604. https://doi.org/10.1161/JAHA.120.018604
Murphy MSQ, Benton SJ, Cox B, Nerenberg K, McComb S, Krishnan L, et al. Maternal Immune Cell and Cytokine Profiles to Predict Cardiovascular Risk Six Months after Preeclampsia. J Clin Med. 2022;11(14):4185. https://doi.org/10.3390/jcm11144185
Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V. Preeclampsia-eclampsia and future cardiovascular risk among women in Taiwan. Taiwan J Obstet Gynecol 2018; 63(18):1815-1822. https://doi.org/10.1016/j.jacc.2014.02.529
Langlois AWR, Park AL, Lentz EJM, Ray JG. Preeclampsia Brings the Risk of Premature Cardiovascular Disease in Women Closer to That of Men. Can J Cardiol 2020;36(1):60-68. https://doi.org/10.1016/j.cjca.2019.06.028
Crump C, Sundquist J, McLaughlin MA, Dolan SM, Govindarajulu U, Sieh W, et al. Adverse pregnancy outcomes and long term risk of ischemic heart disease in mothers: national cohort and co-sibling study. BMJ. 2023;380:e072112. https://doi.org/10.1136/bmj-2022-072112
Sederholm Lawesson S, Swahn E, Pihlsgård M, Andersson T, Angerås O, Bacsovics Brolin E, Bergdahl E, Blomberg M, et al. Association between History of Adverse Pregnancy Outcomes and Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography. JAMA. 2023;329(5):393-404. https://doi.org/10.1001/jama.2022.24093
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pamela Abigail Ocaña-Vicente , Marcos Edisson Bustillos-Solorzano
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
